Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108)
Event updated 07/02/2024
Event updated 07/02/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Clinician consultation on HCV management, HIV management, perinatal HIV/AIDS, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis, substance use. Project period: 2016-2025.
RWHAP Technical Assistance Provider updated on 04/15/2024
RWHAP Technical Assistance Provider updated on 06/17/2024
Resource from the RWHAP Best Practices Compilation updated on 04/12/2024
Resource from the RWHAP Best Practices Compilation updated on 04/12/2024
Resource updated 04/23/2024
Resource from the RWHAP Best Practices Compilation updated on 04/19/2024
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
RWHAP Technical Assistance Provider updated on 04/15/2024
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
HRSA recipients' first point-of-contact for managing federal grants and accessing training and technical assistance.
RWHAP Technical Assistance Provider updated on 04/15/2024
Resource updated 09/14/2023
Resource updated 09/19/2023
Resource updated 09/14/2023
Blog updated 04/17/2024
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023